← Evidence map

ArticleCancers2025

DNA Damage Sensing and TP53 Function as Modulators of Sensitivity to Calicheamicin-Based Antibody-Drug Conjugates for Acute Leukemia.

Camryn M Pettenger-Willey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

DNA Damage Sensing and TP53 Function as Modulators of Sensitivity to Calicheamicin-Based Antibody-Drug Conjugates for Acute Leukemia. | OpenQuestion